share_log
Reuters ·  Apr 25 09:00
BioCardia Completes Enrollment of Cardiamp Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-in Cohort
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment